Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | Neoadjuvant
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Neoadjuvant
*Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B,
Naderi S, Khalilian A, Pourrashidi A, Amjad G, Kolahdouzan K,
Abyaneh R, Jablonska PA, Ghalehtaki R.
Postoperative
NEOadjuvant TEMozolomide followed by chemoradiotherapy versus
upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM)
trial: Interim results.
Neurooncol
Adv. 2024 Nov 14;6(1):vdae195. doi:
10.1093/noajnl/vdae195. PMID:
39664679. Interventional study. ˍ